In the GMP-regulated environment, pharmaceutical mixing plants must be documented and qualified in such a way that their suitability for the intended purpose is demonstrably evidenced. This applies, for example, to solids mixers, container mixers, vacuum mixer dryers, agglomerators, homogenisers, reactors and mobile process containers. Qualification generally comprises the phases Design Qualification, Installation Qualification, Operational Qualification and Performance Qualification.

The documentation required for this does not form a rigid standard list. Its scope depends on a documented risk assessment. Decisive factors include, among others, the product type, dosage form, impact on critical quality attributes, degree of automation, product-contact materials, cleaning strategy, explosion protection, containment and requirements for electronic data. The validation master plan must define strategy, responsibilities, document formats, timelines, change control and the systems to be qualified. Written and approved protocols with critical test steps and acceptance criteria are required for every qualification activity. The results are evaluated in final reports, including deviations, justifications and any necessary corrective actions.

Design Qualification

The Design Qualification documents that the planned plant design meets the requirements from the User Requirement Specification. The User Requirement Specification describes the operator's expectations for the process and the plant. These include, for example, mixing volume, fill level, mixing quality, product-contact materials, temperature and pressure ranges, vacuum operation, cleaning, sterilisation, operability, containment, interfaces and data capture.

The Design Qualification generally includes a functional specification and a design specification. The functional specification describes how the plant is intended to meet the operator's requirements. The design specification sets out the technical execution in concrete terms, for example the mixing tool, drive, seals, sensors, valves, heating and cooling circuits, vacuum technology, CIP or SIP concept, automation and safety devices.

Important DQ documents also include P&ID diagrams, layout and installation plans, component lists, calculations for pressure vessels or structural design, safety concepts, explosion-protection documentation and a documented risk analysis. A risk analysis can be based, for example, on FMEA, HACCP or comparable methods. It identifies critical design elements, critical process parameters and potential effects on product quality, patient safety and data integrity.

A traceability matrix links requirements from the User Requirement Specification with design features, risk analyses, test cases and results from the IQ, OQ and PQ. It creates traceable evidence that every relevant requirement has been tested. Material certificates for product-contact parts, surface requirements, welding concepts and requirements for elastomers should already be specified at this stage.

Installation Qualification

The Installation Qualification demonstrates that the delivered plant has been installed completely, correctly and in accordance with the approved specifications. The IQ protocol contains test points, acceptance criteria, test results, deviations, corrective actions and formal approvals.

Typical IQ documents are up-to-date as-built drawings, layout plans, P&ID diagrams, isometric drawings, electrical circuit diagrams, terminal diagrams, connection overviews, parts lists and component lists. Plant components must be uniquely identifiable by means of nameplates, serial numbers, installation locations and, where applicable, calibration labels.

For product-contact components, material certificates to EN 10204, frequently in the 3.1 form, together with material data, are generally provided. Depending on the application, evidence of surface roughness, passivation, electropolishing or product-contact elastomers is required. For welded components, welding procedure specifications, welder qualifications, welding procedure qualification records, weld seam lists and test protocols form part of the documentation. For permanently piped systems, endoscopy or borescopy evidence can additionally be useful.

The IQ also examines the technical infrastructure. This includes the power supply, earthing, compressed air, pure gases, steam, heating and cooling media, vacuum, purified water, exhaust air and extraction. The installed instrumentation is also cross-checked against drawings, specifications and manufacturer documentation. Calibration certificates must be available for all quality-relevant sensors and measuring instruments. These include, for example, temperature, pressure, vacuum, rotational speed, torque, time, flow, mass and level. EU GMP Annex 15 explicitly names the verification of installation, piping, supply media, instrumentation, calibration, manufacturer documentation and materials as elements of the IQ.

The IQ for an automated mixing plant also includes examination of the underlying software basis. The hardware configuration, version status of the PLC, operator interface, recipe management, interfaces, firmware and network infrastructure are documented. Operating instructions, maintenance schedules, spare parts lists, CE documentation and relevant declarations of conformity are additionally filed.

Operational Qualification

The Operational Qualification demonstrates that the mixing plant functions safely and reproducibly within the specified operating limits. The OQ protocol contains test cases, test steps, target values, limit values, acceptance criteria and the evaluation of the results. The OQ follows a successfully completed IQ.

Typical functional tests cover the mixing tool, start-up and stop behaviour, speed ranges, direction of rotation, torque, dosing points, product discharge, temperature control, pressure and vacuum behaviour, and heating and cooling circuits. Alarms, interlocks, emergency-stop functions, lid monitoring, limit-value alerts and protective functions are additionally tested. The OQ should cover the intended operating range, including justified upper and lower operating limits.

For plants with automated control, recipe management, operating modes, process sequences, operator messages, batch reporting, user roles and interfaces are part of the relevant test scope. Computerised GxP systems must be assessed on a risk basis. GAMP 5 describes an approach for this that ensures computerised systems are effective, of high quality, fit for the intended purpose and regulatory compliant.

For GMP-relevant electronic data, user rights, data backup, recoverability and audit trails must be taken into account. An audit trail is intended to record changes and deletions of GMP-relevant data in a traceable manner. The reason for changes or deletions must be documented. Audit trail data must be available, readable and reviewed at regular intervals.

For plants with CIP or SIP, cleaning and sterilisation functions form part of the OQ. Program sequences, time, temperature, pressure, flow, concentration, valve switching and the actuation of cleaning components, for example, are verified. Riboflavin tests can make the wetting of internal surfaces visible. They are a useful tool, but do not replace product-specific cleaning validation.

Performance Qualification

The Performance Qualification demonstrates that the mixing plant reproducibly delivers specification-compliant results with the intended product or a justified substitute material under conditions close to production. It follows a successfully completed IQ and OQ. The PQ plan describes the product, recipe, process parameters, fill quantities, batch sizes, sampling plan, analytical methods, acceptance criteria and responsibilities. The PQ should include conditions that cover the intended upper and lower operating range.

For pharmaceutical mixing plants, the focus is frequently on homogeneity. Sampling takes place at pre-defined positions and times. Depending on the product, active-ingredient content, content uniformity, moisture, particle size distribution, density, flowability, viscosity or microbiological characteristics are evaluated. Minimum and maximum fill quantities, critical mixing times and other technically justified worst-case conditions can also form part of the PQ.

The number of PQ batches required is not fixed as a blanket rule. The number and selection of trials must be justified by process knowledge, risk analysis and statistical considerations. Batch records, analytical results, trend evaluations, deviations, root-cause analyses and, where applicable, CAPA measures are documented. The final report summarises the results and contains the technical assessment of whether the plant is suitable for the intended routine operation.

Cleaning validation can be part of the Performance Qualification or a stand-alone validation package. It covers defined limit values, representative sampling points and suitable analytical methods. Depending on the product and the risk, swab samples, rinse samples, TOC analyses, product-specific residue analysis or microbiological examinations are used. The evidence must demonstrate that residues of product and cleaning agents, as well as relevant microbial loads, do not exceed the defined limit values.

Supplementary documentation

FAT and SAT protocols can be used for the IQ and OQ following a risk-based assessment. The Factory Acceptance Test is carried out at the supplier's premises and confirms agreed mechanical, functional and control-related requirements prior to delivery. The Site Acceptance Test takes place after installation at the operator's site and checks in particular the condition after transport, connections, interfaces and functions under the real operating conditions.

Change control documentation, deviation reports, maintenance schedules, calibration schedules, requalification plans and standard operating procedures are additionally required. Training records for operation, maintenance and quality assurance demonstrate that the plant is operated, cleaned, maintained and monitored only by qualified personnel.

Qualification documentation can be produced in multiple languages where this is required for international sites, supply chains or inspections. What matters most, however, is not the language alone, but clear version control, formal approval, traceable archiving and the availability of the documentation at all times during audits and inspections.

A risk-based approach prevents both under-documentation and unnecessary documentation effort. Critical design elements and functions with a direct impact on product quality, patient safety or data integrity receive a more in-depth level of testing and documentation. Standard components with low risk can be treated in an appropriately leaner manner, provided the justification is documented. Early coordination between the operator, quality assurance, validation, engineering and the plant supplier reduces later follow-up requests and facilitates the transition of the mixing plant into GMP-compliant routine operation.